Pharmaceutical

The Asia Pacific region is one of the global hubs for manufacturing and accounts for nearly 48.5 percent of the worldwide manufacturing output. Now, more countries in the region are developing advanced manufacturing capabilities to grow Industry 4.0. These emerging technologies also play a crucial role in helping us achieve our decarbonisation goals, as sustainability becomes a core priority in business operations. 

Five largest chemical and pharmaceutical construction projects were initiated in SEA Q2 2022 :

1. Tuas Biomedical Park New Vaccine Production Facility – $467m

The project involves the construction of a new vaccine production facilities at Tuas Biomedical Park in Singapore.

Construction work started in Q2 2022 and is expected to be completed in Q1 2026.

2. Yeosu Mononitrobenzene Manufacturing Plant – $375m

The project involves the construction of a Mononitrobenzene manufacturing plant with a production capacity of 300,000 tons per annum at Yeosu Industrial Complex, Jeollanam-do, South Korea. Construction work commenced in Q2 2022 and is expected to finish in Q2 2024.

3. Yeosu Dilute Nitric Acid Manufacturing Plant – $135m

The project involves the construction of a dilute nitric acid manufacturing plant with a production capacity of 400,000 tons per annum at Yeosu Industrial Complex, Jeollanam-do, South Korea. Construction work started in Q2 2022 and is forecast to complete in Q3 2022.

4. Kochi Integrated Fertilizer Complex – $34m

The project involves the construction of an integrated fertilizer complex with a production capacity of 1,650 TPD NP in Kochi, Kerala, India. Construction work commenced in Q2 2022 and is expected to be completed in Q4 2024.

5. Darong Import Facility – $33m

The project involves the construction of an import facilities in Darong, the Philippines. Construction work started in Q2 2022 and is expected to be completed in Q3 2024.